Editor's Note :

Editor's Note :

There is a possibility of opinions on Wednesday, March 1.
On Monday the court hears oral argument in Packingham v. North Carolina. Amy Howe has our preview.
On Monday the court also hears oral argument in Esquivel-Quintana v. Sessions. Kevin Johnson has our preview.

Breaking News :

Breaking News :

Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S

Docket No. Op. Below Argument Opinion Vote Author Term
10-844 Fed. Cir. Dec 5, 2011
Tr.Aud.
Apr 17, 2012 9-0 Kagan OT 2011
 
Share:

Holding: A generic drug manufacturer may employ the counterclaim provision of the Hatch-Waxman Act to force correction of a use code that inaccurately describes the brand’s patent as covering a particular method of using a drug.

Plain English Summary:

Judgment: Reversed and remanded, 9-0, in an opinion by Justice Kagan on April 17, 2012. Justice Sotomayor filed a concurring opinion.

SCOTUSblog Coverage

CVSG Information

Invited: March 28, 2011

Filed: May 26, 2011 (Grant)

Briefs and Documents

Merits Briefs for Petitioners Amicus Briefs Supporting Petitioners Merits Briefs for the Respondents Amicus Briefs Supporting the Respondents

Certiorari-stage documents

Term Snapshot
Awards